– ATH434 Phase 2 data demonstrated clinically meaningful efficacy on multiple clinical endpoints –
Alterity Therapeutics Prominently Featured at the International MSA Congress
Seeking Alpha / 11 hours ago 2 Views
Seeking Alpha / 11 hours ago 2 Views
– ATH434 Phase 2 data demonstrated clinically meaningful efficacy on multiple clinical endpoints –
Comments